Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Rienso (ferumoxytol) - Important Safety Information from Takeda Development Centre Europe Ltd. as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
12/02/2014
Problem Or Issue:
Important Safety Information communication from Takeda Development Centre Europe Ltd. on strengthened recommendations regarding the risk of serious hypersensitivity reactions with Rienso (ferumoxytol).
Important Safety Information - Rienso (ferumoxytol)
« Back
Date Printed: 02/05/2024